$ValueMax(T6I.SI)$ 2 Target Price by WallStreet analyst. ValueMax Group (SGX:T6I) Simply Wall St Value Rating: ★★★★ Overview: ValueMax Group operates in pawnbroking, moneylending, and the retail and trading of jewellery and gold, with a market capitalization of approximately SGD 0.48 billion. Operations: The company generates revenue primarily from retail and trading of jewellery and gold, alongside pawnbroking and moneylending services. The gross profit margin has shown a notable trend, increasing from 6.65% in mid-2014 to 28.45% by the end of 2025. Operating expenses have been a consistent component of the cost structure, with general and administrative expenses being significant contributors. PE: 5.5x ValueMax Group, a small company in Asia,

$CNMC Goldmine(5TP.SI)$ 2 Target Price. CNMC Goldmine(5TP) will upsurge in coming weeks due to discovery of rare metals deposits, global geopolitical tension in middle-east & latin American, distrust in U.S treasury bonds and it's currency. China Nonferrous Metal Mining Group (CNMC) has recently discovered rare metal earth deposits, on top of GOLD ores, in it's Sokor Gold field, Malaysia. Production Expansion: CNMC Goldmine's carbon-in-leach (CIL) plant expansion has increased daily processing capacity to 800 tonnes, supporting higher output potential. - Earnings Growth: Strong FY-2025 earning growth, with a 40% net profit increase in Year-2025 PATMI to US$42 million. *Analyst Price Target for CNMC:* - Phillip Securities has a BUY rating wit

$REALLOYS INC(ALOY)$  

$PanUnited(P52.SI)$ 2 Target Price. *Growth Catalysts for Pan-United Corporation (P52.SI)* Pan-United is Singapore's  largest ready-mixed concrete producer, and analysts see several drivers supporting growth into 2026-2027: 1). Singapore Construction Demand Surge - *Public sector pipeline*: New HDB developments, Cross Island Line, Tuas Mega Port, and institutional projects are expected to drive ∼55% of total construction demand. - *RMC volume growth*: Ready-mix concrete demand is projected to jump 34% from 13.4 million m³ in 2024 to 18 million m³ by 2027. - Analysts forecast EPS for Pan-United to grow 6-22% in FY26-FY27 on stronger offtake volume. *2. ESG & Low-Carbon Concrete Leadership* - Pan-United specializes in low-carbon concrete

$IX Biopharma(42C.SI)$ 0.8 Target Price. --iX Biopharma Ltd(42C) Growth Catalysts-- Shift towards commercialisation of WaferiX subligual delivery of drugs could bump up revenue by as much as 250% in FY-2026, backed by planned capacity expansion. Out-licensing of the sublingual ketamine wafer, Wafermine, for Phase 3 development will be a major catalyst and expected to turn iX Biopharma profitable in long-term.  Specialty pharmaceutical and nutraceutical drugs will benefit from the planned six-fold increase in production capacity to meet the expected surge in demand. Investment Merits Out-licensing world's first sublingual ketamine formula, Wafermine, for Phase 3 development is a near-term catalyst. Since the completion of its end-of-Ph

$REALLOYS INC(ALOY)$ $18 Target Price -- About Realloys Inc (ALOY)-- RealLoys Inc is at the centre of a major US policy push to build a domestic rare-earth supply chain, which has driven significant  bullish momentum and impact on it's defence and eletronic sector. -- Growth Catalysts for ALOY-- 1). Trump Key Minerals & Rare Earth Company listing in Aug-2026 President Trump hosted 200+ mining executives and announced ~US$3 billion in federal funding for critical minerals. ALOY surged ~15% on the day, alongside the broader US rare-earth sector. Trump Public Endorsement of ALOY 08-Aug-2026 In a live interview, Trump explicitly named ALOY as a core upstream supplier for the US permanent-magnet supply chain, stating it would r

$IX Biopharma(42C.SI)$ $0.8 Target Price --About IX Biopharma (42C.SI)-- iX Biopharma Ltd (SGX: 42C) is a specialty pharmaceutical and nutraceutical company focused on developing, manufacturing, and commercializing products using its proprietary sublingual drug delivery technologies. Its core growth catalysts center on commercial technology expansion, U.S. market entry, and joint venture/licensing opportunities. --Growth Catalysts for iX Biopharma-- 1). Commercialization & Out-Licensing of WaferiX®: Monetization of its patented sublingual wafer platform (WaferiX®, WaferlogiX) via out-licensing deals, tech transfers, and manufacturing agreements for repurposed pharmaceutical molecules (such as Wafermine for pain management and Wafesil f

$Hong Leong Asia(H22.SI)$ $3.8 Target Price --Growth Catalysts for Hong Leong Asia (H22.SI)-- Hong Leong Asia's key growth catalysts centre on three pillars: (1) a proposed spin-off and Hong Kong listing of a subsidiary, which could unlock significant embedded value, (2) strong operating momentum and Q1-2026 earnings from its core engine business via China Yuchai International (CYD), and (3) a healthy balance sheet supporting both organic expansion and shareholder returns. The stock trades at a modest P/S of 0.47x, suggesting the market may not be fully pricing in these catalysts. (1). Proposed Spin-Off & HK Listing of Subsidiary On 28 January 2026, Hong Leong Asia announced plans to spin off an indirect subsidiary and list it on the H

It's much cheaper to buy-in these high valued U.S stocks at SGX and also the SGD profit/loss is unaffected by the U.S Currency rate.

$QAF(Q01.SI)$ $1.2 Target Price --Overview of QAF -- QAF Limited (SGX: Q01), a regional multi-brand food player known for flagship brands like Gardenia and Cowhead, drives its operational growth through core distribution network expansion, brand power, supply chain scale, and disciplined capital allocation.   --Growth Catalysts for QAF-- 1). Dominant Market Leadership & Pricing Power (Bakery Division): As a market leader in packaged bread across Singapore, Malaysia, and the Philippines under the Gardenia banner, QAF maintains structural pricing power. Strong brand equity allows the group to pass on elevated raw material (wheat, flour) and energy costs to retail prices without severe volume destruction. 2). Expansion of D

$Sheng Siong(OV8.SI)$  $3.60 Target Price. --Overview of Sheng Siong (OV8)-- Sheng Siong Group Ltd (SGX: OV8) relies on a mix of store network expansion, operational efficiency, macro-driven demand, and new sales channels to drive its core financial performance. --Growth Catalysts for ShengSiong-- 1). Aggressive Store Expansion Pipeline: The company's primary growth engine remains physical store network expansion. Adding 16 new stores in Singapore between 2025 and 1H 2026, Sheng Siong operates 90 domestic outlets alongside 6 overseas stores in Kunming, China. Future pipeline visibility is secured through upcoming openings in new housing developments like Hougang, Rivervale, and Woodlands, alongside ongoin

$JustCo(JCO.SI)$ 1 Target Price.  Based on the just-released H1-2026 results, the company's growth trajectory, and broker commentary, JustCo's Q3 2026 (July–September) is on track to deliver continued revenue growth in the low-to-mid 20% range YoY , with a modest but positive pre-exceptional net profit — marking a sustained turnaround from the loss-making years of FY2023–FY2024. Key Data Points 1. H1 2026 Actuals (Just Released) Metric H1-2026 H1-2025 YoY Change Revenue USD 80.8M USD 65.1M +24% Pre-exceptional Net Profit USD 0.1M The H1-2026 results confirmed the inflection point: JustCo swung from loss to pre-exceptional profitability on 24% revenue growth, driven by higher workstation yields and stronger pricing. 2. Historical Annual Tre

$Sheng Siong(OV8.SI)$  $3.70 Target Price. About Sheng Siong (OV8) Sheng Siong Group is one of Singapore's largest supermarket chains, operating over 88 outlets primarily in residential heartland locations, alongside stores in Kunming, China and its Sheng Siong Online grocery platform. As a consumer staples play, the group offers a defensive earnings profile anchored by consistent demand for daily essentials. Fundamentals Sheng Siong reported 1Q FY2026 revenue of S$452.8M, up 12.4% YoY, with net profit rising 12.6% to S$43.4M, driven mainly by the twelve new stores opened during FY2025 alongside stronger festive spending over Lunar New Year and Hari Raya Puasa. Comparable same-store revenue in Singapore grew 3.5%,

$JustCo(JCO.SI)$ 1 Target Price.    JustCo (JCO.SI) has clear and visible growth catalysts driven by aggressive physical expansion and strong industry tailwinds. The company is executing a well-defined strategy to increase its workstation capacity and is backed by strong shareholder support, positioning it to capitalize on the growing demand for flexible workspaces in Asia Pacific. --JCO Growth Catalysts-- 1. Strong Expansion Pipeline & Scale JustCo's primary growth catalyst is its visible expansion plan. Maybank Research forecasts the company's workstation capacity will grow at a 19.5% CAGR from YR2025-2028. This expansion is already underway: New Locations: The company recently launched a new co-working space ("The Boring Office"

$Silvercorp Metals Inc(SVM)$ $15 Target Price on global physical Silver demand deficit. Growth Catalysts for SVM Silvercorp Metals (SVM) has made some exciting recent discoveries. At their LMW underground mine in China's Ying Mining District, they've found high-grade silver, gold, and copper mineralization. Some notable intercepts include: - *2,705 g/t silver* over 18.02 meters in vein W18W - *34 g/t gold* and *4.45% copper* over 0.82 meters in vein LM28 - *4,738 g/t silver* over 1.80 meters in vein LM32E   These discoveries have expanded known mineralized zones and identified new vein structures with high-grade mineralization. The company is also advancing the El Domo Project in Ecuador, with construction expected to be completed by Q2-2026,

$Sheng Siong(OV8.SI)$  $3.60 Target Price. About Sheng Siong (OV8) Sheng Siong Group is one of Singapore's largest supermarket chains, operating over 88 outlets primarily in residential heartland locations, alongside stores in Kunming, China and its Sheng Siong Online grocery platform. As a consumer staples play, the group offers a defensive earnings profile anchored by consistent demand for daily essentials.  Fundamentals  Sheng Siong reported 1Q FY2026 revenue of S$452.8M, up 12.4% YoY, with net profit rising 12.6% to S$43.4M, driven mainly by the twelve new stores opened during FY2025 alongside stronger festive spending over Lunar New Year and Hari Raya Puasa. Comparable same-store revenue in Singapore

$JustCo(JCO.SI)$ 1 Target Price JustCo (JCO.SI) has clear and visible growth catalysts driven by aggressive physical expansion and strong industry tailwinds. The company is executing a well-defined strategy to increase its workstation capacity and is backed by strong shareholder support, positioning it to capitalize on the growing demand for flexible workspaces in Asia Pacific. --JCO Growth Catalysts-- 1. Strong Expansion Pipeline & Scale JustCo's primary growth catalyst is its visible expansion plan. Maybank Research forecasts the company's workstation capacity will grow at a 19.5% CAGR from YR2025-2028. This expansion is already underway: New Locations: The company recently launched a new co-working space ("The Boring Office") in Singapore's CBD and signed a master lease for a ~150,0

$PC Partner(PCT.SI)$ 3.50 Target Price   PC Partner's primary growth catalyst is a structural improvement in profitability driven by a richer product mix (higher Average Selling Prices/ASPs) and operational leverage, supported by strong underlying demand. PC Partner Group (PCT.SI) forecasts a net profit of no less than SGD 500 million for H1-2026. --Key Catalysts and Supporting Data--- 1. Product Mix Upgrade & ASP Expansion The company directly attributes its H1 2026 profit surge to "higher average selling prices of its branded products". This indicates a successful shift towards premium, higher-margin GPU models. This catalyst is already visible in the financials. In FY2025 (annual), Gross Profit grew 48.92% YoY to HKD 1.42B, significa